Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug
Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug
Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug
Submitted by
admin
on April 14, 2017 - 10:48am
Source:
Marketwatch
News Tags:
Eli Lilly
Incyte
FDA
rheumatoid arthritis
baricitinib
Headline:
Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug
Do Not Allow Advertisers to Use My Personal information
